Age was the only factor to exert influence on this outcome ( P =.

Mean HbA1C was a half percentage point lower, however, among that 19% vs all of the other groups combined: 7.2% (1.2% ) vs 7.7% (1.4% ) P =. Few analyzed their CGM data on a regular basis just 19% reported doing so, and 12% said they never did. 823).įollowing evaluation of CGM satisfaction-with opinions solicited on such items as feelings of security, impact on sleep, easy to use, and adequacy of alarms-98% self-reported an improvement to their overall well-being compared with SMBG. Further, more than a third (35%) had a total score of 8 or higher, “indicating an elevated level of diabetes distress,” the authors wrote, and this finding was independent of type of glucose monitoring ( P =. PAID-5 scores were also close to equal among SMBG (5.64 ), iscCGM (6.23 ), and rtCGM (6.43 ) users ( P =. 033) exerted the greatest influence on this outcome.įollowing administration of the PAID-5, females reported greater distress vs males the mean scores were 6.72 (4.45) and 4.57 (3.94), respectively. 001), and longer diabetes duration ( P =. Fifty-five percent of the entire cohort met the HbA1C target of less than 7.5% (58 mmol/mol), and younger age ( P <. 005) and had received their diabetes diagnosis the farthest back ( P <. In addition, rtCGM users were older ( P =. Insulin pump use was greatest among rtCGM users, followed by iscCGM and SMBG users, at 80%, 57%, and 43%, respectively. Overall, the mean (SD) age was 21.4 (3.5) years, mean diabetes duration was 10.1 (5.9) years, most (61%) used an insulin pump, mean HbA1C was 7.7% (1.5%), and mean PAID-5 score was 6.15 (4.42). Most participants were female and older than 20 years. Surveys of adolescents and young adults are still rare.”Īmong the entire study cohort of 308 patients, 141 (46%) reported intermittent-scanning continuous glucose monitoring (iscCGM) 91 (30%), real-time continuous glucose monitoring (rtCGM) and 76 (24%), self-monitoring of blood glucose (SMBG). “However, most of these studies focused on adults with diabetes or parents of children with diabetes. “A high level of satisfaction with CGM use was shown in various clinical trials and qualitative studies, especially in patients with a high risk of hypoglycemia,” the authors explained. Each question of the PAID-5 is graded on a scale from 0 (not a problem) to 4 (serious problem). In addition to their principal conclusion, the study investigators also found that neither diabetes distress, as measured via the Problem Areas in Diabetes Scale (PAID)-5, or glycemic control were improved. These survey findings, and others, were published in a recent issue of Journal of Diabetes Science and Technology, following anonymous administration of a survey during the 4-day nationwide youth diabetes camp, Camp D, in 2018. Treatment satisfaction has been very high and hemoglobin A1C (HbA1C) levels have been lowered following the move by German health insurance companies in 2016 to reimburse patients with insulin-dependent diabetes for their continuous glucose monitors (CGMs).

Cgm findings vs